Fusion Gene Studies
in Kim Lab

FusionBase FusionGDB FusionGDB2 FusionPDB FusionNeoAntigen FusionAI FusionNW FGviewer Publication Contact
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:ESR2-SCARB1 (FusionGDB2 ID:HG2100TG949)

Fusion Gene Summary for ESR2-SCARB1

check button Fusion gene summary
Fusion gene informationFusion gene name: ESR2-SCARB1
Fusion gene ID: hg2100tg949
HgeneTgene
Gene symbol

ESR2

SCARB1

Gene ID

2100

949

Gene nameestrogen receptor 2scavenger receptor class B member 1
SynonymsER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2|ODG8CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1
Cytomap('ESR2')('SCARB1')

14q23.2-q23.3

12q24.31

Type of geneprotein-codingprotein-coding
Descriptionestrogen receptor betaestrogen receptor beta 4estrogen receptor beta splice variant, ERbeta2delta7estrogen receptor beta splice variant, ERbeta4delta7estrogen receptor beta splice variant, ERbeta6estrogen receptor beta splice variant, ERbeta6delta7escavenger receptor class B member 1CD36 and LIMPII analogous 1CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 1scavenger receptor class B type III
Modification date2020032220200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST00000267525, ENST00000341099, 
ENST00000353772, ENST00000357782, 
ENST00000358599, ENST00000542956, 
ENST00000553796, ENST00000554572, 
ENST00000555278, ENST00000555483, 
ENST00000557772, 
Fusion gene scores* DoF score1 X 1 X 1=16 X 11 X 10=660
# samples 118
** MAII scorelog2(1/1*10)=3.32192809488736log2(18/660*10)=-1.87446911791614
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: ESR2 [Title/Abstract] AND SCARB1 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointESR2(64694132)-SCARB1(125308400), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneESR2

GO:0000122

negative regulation of transcription by RNA polymerase II

15345745

HgeneESR2

GO:0045893

positive regulation of transcription, DNA-templated

20074560

HgeneESR2

GO:0051091

positive regulation of DNA-binding transcription factor activity

10681512

TgeneSCARB1

GO:0010886

positive regulation of cholesterol storage

9211901

TgeneSCARB1

GO:0015920

lipopolysaccharide transport

12651854

TgeneSCARB1

GO:0032497

detection of lipopolysaccharide

12651854

TgeneSCARB1

GO:0034384

high-density lipoprotein particle clearance

9211901

TgeneSCARB1

GO:0043654

recognition of apoptotic cell

9211901

TgeneSCARB1

GO:0051000

positive regulation of nitric-oxide synthase activity

11792700



check button Fusion gene information
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand


Top

Fusion Gene ORF analysis for ESR2-SCARB1

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for ESR2-SCARB1


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)


Top

Fusion Protein Features for ESR2-SCARB1


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:64694132/:125308400)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
..
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for ESR2-SCARB1


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for ESR2-SCARB1


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for ESR2-SCARB1


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

Related Diseases for ESR2-SCARB1


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneESR2C0033578Prostatic Neoplasms6CTD_human
HgeneESR2C0376358Malignant neoplasm of prostate6CTD_human
HgeneESR2C0006142Malignant neoplasm of breast3CTD_human
HgeneESR2C0036341Schizophrenia3PSYGENET
HgeneESR2C0678222Breast Carcinoma3CTD_human
HgeneESR2C1257931Mammary Neoplasms, Human3CTD_human
HgeneESR2C1458155Mammary Neoplasms3CTD_human
HgeneESR2C4704874Mammary Carcinoma, Human3CTD_human
HgeneESR2C0001418Adenocarcinoma1CTD_human
HgeneESR2C0003811Cardiac Arrhythmia1CTD_human
HgeneESR2C0004114Astrocytoma1CTD_human
HgeneESR2C0004238Atrial Fibrillation1CTD_human
HgeneESR2C0005684Malignant neoplasm of urinary bladder1CTD_human
HgeneESR2C0005695Bladder Neoplasm1CTD_human
HgeneESR2C0007097Carcinoma1CTD_human
HgeneESR2C0007138Carcinoma, Transitional Cell1CTD_human
HgeneESR2C0009171Cocaine Abuse1CTD_human
HgeneESR2C0009402Colorectal Carcinoma1CTD_human
HgeneESR2C0009404Colorectal Neoplasms1CTD_human
HgeneESR2C0010054Coronary Arteriosclerosis1CTD_human
HgeneESR2C0010068Coronary heart disease1CTD_human
HgeneESR2C0014170Endometrial Neoplasms1CTD_human
HgeneESR2C0014175Endometriosis1CTD_human
HgeneESR2C0021361Female infertility1CTD_human
HgeneESR2C0023869Lithiasis1CTD_human
HgeneESR2C0024667Animal Mammary Neoplasms1CTD_human
HgeneESR2C0024668Mammary Neoplasms, Experimental1CTD_human
HgeneESR2C0025149Medulloblastoma1CTD_human
HgeneESR2C0038279Sterility, Postpartum1CTD_human
HgeneESR2C0041696Unipolar Depression1PSYGENET
HgeneESR2C0205641Adenocarcinoma, Basal Cell1CTD_human
HgeneESR2C0205642Adenocarcinoma, Oxyphilic1CTD_human
HgeneESR2C0205643Carcinoma, Cribriform1CTD_human
HgeneESR2C0205644Carcinoma, Granular Cell1CTD_human
HgeneESR2C0205645Adenocarcinoma, Tubular1CTD_human
HgeneESR2C0205696Anaplastic carcinoma1CTD_human
HgeneESR2C0205697Carcinoma, Spindle-Cell1CTD_human
HgeneESR2C0205698Undifferentiated carcinoma1CTD_human
HgeneESR2C0205699Carcinomatosis1CTD_human
HgeneESR2C0205768Subependymal Giant Cell Astrocytoma1CTD_human
HgeneESR2C0205833Medullomyoblastoma1CTD_human
HgeneESR2C0235480Paroxysmal atrial fibrillation1CTD_human
HgeneESR2C0236736Cocaine-Related Disorders1CTD_human
HgeneESR2C0269102Endometrioma1CTD_human
HgeneESR2C0278510Childhood Medulloblastoma1CTD_human
HgeneESR2C0278876Adult Medulloblastoma1CTD_human
HgeneESR2C0280783Juvenile Pilocytic Astrocytoma1CTD_human
HgeneESR2C0280785Diffuse Astrocytoma1CTD_human
HgeneESR2C0282612Prostatic Intraepithelial Neoplasias1CTD_human
HgeneESR2C0334579Anaplastic astrocytoma1CTD_human
HgeneESR2C0334580Protoplasmic astrocytoma1CTD_human
HgeneESR2C0334581Gemistocytic astrocytoma1CTD_human
HgeneESR2C0334582Fibrillary Astrocytoma1CTD_human
HgeneESR2C0334583Pilocytic Astrocytoma1CTD_human
HgeneESR2C0338070Childhood Cerebral Astrocytoma1CTD_human
HgeneESR2C0341869Subfertility, Female1CTD_human
HgeneESR2C0476089Endometrial Carcinoma1CTD_human
HgeneESR2C0547065Mixed oligoastrocytoma1CTD_human
HgeneESR2C0588008Severe depression1PSYGENET
HgeneESR2C0600427Cocaine Dependence1CTD_human
HgeneESR2C0750935Cerebral Astrocytoma1CTD_human
HgeneESR2C0750936Intracranial Astrocytoma1CTD_human
HgeneESR2C0751291Desmoplastic Medulloblastoma1CTD_human
HgeneESR2C0917730Female sterility1CTD_human
HgeneESR2C1257925Mammary Carcinoma, Animal1CTD_human
HgeneESR2C1269683Major Depressive Disorder1PSYGENET
HgeneESR2C1275668Melanotic medulloblastoma1CTD_human
HgeneESR2C1704230Grade I Astrocytoma1CTD_human
HgeneESR2C1833921Familial medullary thyroid carcinoma1ORPHANET
HgeneESR2C1956346Coronary Artery Disease1CTD_human
HgeneESR2C2585653Persistent atrial fibrillation1CTD_human
HgeneESR2C3468561familial atrial fibrillation1CTD_human
HgeneESR2C4748626OVARIAN DYSGENESIS 81UNIPROT
TgeneC0006868Cannabis Abuse1CTD_human
TgeneC0006870Cannabis Dependence1CTD_human
TgeneC0007097Carcinoma1CTD_human
TgeneC0007134Renal Cell Carcinoma1CTD_human
TgeneC0009171Cocaine Abuse1CTD_human
TgeneC0016427Follicular cyst1CTD_human
TgeneC0018614Hashish Abuse1CTD_human
TgeneC0019196Hepatitis C1CTD_human
TgeneC0022661Kidney Failure, Chronic1CTD_human
TgeneC0024667Animal Mammary Neoplasms1CTD_human
TgeneC0024668Mammary Neoplasms, Experimental1CTD_human
TgeneC0024809Marijuana Abuse1CTD_human
TgeneC0031391Phencyclidine Abuse1CTD_human
TgeneC0205696Anaplastic carcinoma1CTD_human
TgeneC0205697Carcinoma, Spindle-Cell1CTD_human
TgeneC0205698Undifferentiated carcinoma1CTD_human
TgeneC0205699Carcinomatosis1CTD_human
TgeneC0236735Cannabis-Related Disorder1CTD_human
TgeneC0236736Cocaine-Related Disorders1CTD_human
TgeneC0236742Phencyclidine-Related Disorders1CTD_human
TgeneC0279702Conventional (Clear Cell) Renal Cell Carcinoma1CTD_human
TgeneC0400966Non-alcoholic Fatty Liver Disease1CTD_human
TgeneC0600427Cocaine Dependence1CTD_human
TgeneC1257925Mammary Carcinoma, Animal1CTD_human
TgeneC1266042Chromophobe Renal Cell Carcinoma1CTD_human
TgeneC1266043Sarcomatoid Renal Cell Carcinoma1CTD_human
TgeneC1266044Collecting Duct Carcinoma of the Kidney1CTD_human
TgeneC1306837Papillary Renal Cell Carcinoma1CTD_human
TgeneC1853096HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 61CTD_human;GENOMICS_ENGLAND
TgeneC3241937Nonalcoholic Steatohepatitis1CTD_human